Changeflow GovPing Pharma & Drug Safety MEND II mindfulness neurostimulation for depres...
Routine Notice Added Final

MEND II mindfulness neurostimulation for depression, UC San Diego

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected April 6th, 2026
Email

Summary

The National Library of Medicine registered a new clinical trial, NCT07512284, on ClinicalTrials.gov. The MEND II study will investigate mindfulness neurostimulation as an intervention for depression at UC San Diego.

What changed

A new clinical trial registration has been filed for the MEND II study, examining mindfulness and neurostimulation for treating depression at UC San Diego. The trial is registered as NCT07512284.

Clinical investigators and study sponsors must ensure this registration is maintained with current information per FDA requirements under 42 CFR Part 11. Patients interested in participating should review the trial details and eligibility criteria on ClinicalTrials.gov.

Source document (simplified)

Show glossary

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
NLM
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07512284

Who this affects

Applies to
Healthcare providers Patients Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical Trial Registration
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.